Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Subscribe To Our Newsletter & Stay Updated